Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|January 14, 2015
The current status and prospects of antibody engineering for therapeutic use: focus on glycoengineering technologyRinpei Niwa, Mitsuo Satoh
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 2, 2010
Optimizing therapeutic antibody function: progress with Fc domain engineeringEtsuji Kaneko, Rinpei Niwa
Drug Design, Development and Therapy|November 19, 2009
Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDCAkito Natsume, Rinpei Niwa, Mitsuo Satoh
Leukemia Research|December 22, 2009
Nonfucosylated anti-CD20 antibody potentially induces apoptosis in lymphoma cells through enhanced interaction with FcgammaRIIIb on neutrophilsTomoaki Nakagawa, Akito Natsume, Mitsuo Satoh, et al.
Anticancer Research|October 15, 2010
Novel anti-Tn single-chain Fv-Fc fusion proteins derived from immunized phage library and antibody Fc domainTsuguo Kubota, Takefumi Matsushita, Rinpei Niwa, et al.
Cancer Science|September 18, 2009
Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activityAkito Natsume, Yukiko Shimizu-Yokoyama, Mitsuo Satoh, et al.
Cancer Science|June 23, 2009
Engineered therapeutic antibodies with improved effector functionsTsuguo Kubota, Rinpei Niwa, Mitsuo Satoh, et al.
Cancer Science|March 29, 2022
Novel cancer-specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long-term survivalSayaka Takagi-Maeda, Satoshi Yajima, Takashi Suzuki, et al.
Journal of Biochemistry|October 14, 2006
Enhanced Fc-dependent cellular cytotoxicity of Fc fusion proteins derived from TNF receptor II and LFA-3 by fucose removal from Asn-linked oligosaccharidesEmi Shoji-Hosaka, Yukari Kobayashi, Masako Wakitani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen densityRinpei Niwa, Mikiko Sakurada, Yukari Kobayashi, et al.
Pageof 3